{"name":"Hyundai Pharm","slug":"hyundai-pharm","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Acebrophylline","genericName":"Acebrophylline","slug":"acebrophylline","indication":"Other","status":"phase_3"},{"name":"Levotuss","genericName":"Levotuss","slug":"levotuss","indication":"Other","status":"phase_3"},{"name":"Surfolase CR","genericName":"Surfolase CR","slug":"surfolase-cr","indication":"Other","status":"phase_1"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"BPDO-1603","genericName":"BPDO-1603","slug":"bpdo-1603","indication":"Hypertension","status":"phase_3"}]}],"pipeline":[{"name":"Acebrophylline","genericName":"Acebrophylline","slug":"acebrophylline","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BPDO-1603","genericName":"BPDO-1603","slug":"bpdo-1603","phase":"phase_3","mechanism":"BPDO-1603 is a small molecule that targets the renin-angiotensin system to lower blood pressure.","indications":["Hypertension"],"catalyst":""},{"name":"Levotuss","genericName":"Levotuss","slug":"levotuss","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Surfolase CR","genericName":"Surfolase CR","slug":"surfolase-cr","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBhS1NqbHcwbXFTSFBDY0RpQkR5V25vTm1CWGhmX2ZlYzVBakhUZXNvalZWVG1QaFMwMkxzZVdsaVVPdVVPeTFLd1Q1eEQyUnAyNnFNazhmTUhEcFUzRFQ2dU9DRW5nMnk2aVB1RTNn0gFyQVVfeXFMTkl1bHI0bTl3Rm5yRFlsX1VVVnNNM3pHM3MwWkZ5Tm5FMlVZeHdST19SRUFhdHNIcGdUTE5ZMEwyX05UWFJVQmdZQXB1ZVM1bW9ja0tqWE50R0dJb2xqeEpfSV9OSWduZDh4bXBqWDEyVDZn?oc=5","date":"2026-03-24","type":"pipeline","source":"koreabiomed.com","summary":"Hyundai Pharm’s Alzheimer’s combo added to major hospital formularies - koreabiomed.com","headline":"Hyundai Pharm’s Alzheimer’s combo added to major hospital formularies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBQNklPdXhlb2ZaS3pRc2hCY0doS09yWkJxVE03OEZTb1QtTmV5MGYzcnJQTEUyUWdnOHg0RUZlbEJuUmNoTWFXNDBQd0hkWmk1Q0MtMGlEWHY4NENVeXBSTEQxVVRheVB1Uy1LYnJ30gFyQVVfeXFMUEViQnNBazkya3Rhd3hzWmxxRWtqZFNkMmxvUjk3MTY5OVROSl8waUh3aVB1RUpKcHNuOHUzdnVXaVF6cHJCMVVTVXVpTTgtcXRTYVpYVjc2UXZWa3V4Sm56RlN2X3A3bFJReGVWMXFTck53?oc=5","date":"2026-03-05","type":"pipeline","source":"koreabiomed.com","summary":"Korean pharma braces for governance reforms, CEO renewals in March meetings - koreabiomed.com","headline":"Korean pharma braces for governance reforms, CEO renewals in March meetings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOYWNaS2Q3QUV2b3BDR3kyVFk1a0pIaDl4U250VlljSDNNaTlMYUhTYU5TQjU2R1ROLUVhUlVKbVVnUHotVl96UUV2RTU3UjNXckJjZUdXQlY3SUFpNkR3ZFVCb2ZRbkhjQ1FQdzZvQ2lWMWtaRzVlV2xFYWE3eXZNcEhsT0RkcU1N?oc=5","date":"2025-12-10","type":"pipeline","source":"조선일보","summary":"Cosmo's 30-Year Hair Loss Breakthrough - 조선일보","headline":"Cosmo's 30-Year Hair Loss Breakthrough - 조선일보","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1WZV9wZTVvclByNU8wenF3WmtRUTNNdXc4MVE3WUJtMTd6RG54M2JWeGlNa0FrV05PVG1YbXU1SjJIYmdfMVQ3UHU3MVU2YkdYNTNoRzQtbE9xNW9PNVFicEQyX01zVkR1N0RFNVdNTkNraWxJc0Fr?oc=5","date":"2025-10-08","type":"regulatory","source":"The Korea News Plus","summary":"Hyundai Pharm to sell Cosmo product approved in South Korea - The Korea News Plus","headline":"Hyundai Pharm to sell Cosmo product approved in South Korea","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1DS2RjeFE3WllieUViVHVlVmQ5LXhTNDVwQm51VHpZdkpBNC1HSEVHdHU0UGhDWXNQekRubTI4dXNLT3lYY2g0ZEthYWdrRFR3OVIya1Uta3Jna0VYcmhSLVNMYk9jbFhoWERpR2hn0gFyQVVfeXFMT1FkQ19GUFlSREkxalF0bzl6ZUdGUkszYjd3VzJWZld0RTBiS3F0WUxvOUlVNzBFMnRIdmhqb281Zktnb3I5UkpwcV9uY2xlbFQwUjVSSXU4bm1zS0ZyX0hoU2hHQl9YaU9IZ25ydVplVGtB?oc=5","date":"2025-10-02","type":"pipeline","source":"koreabiomed.com","summary":"Hyundai Pharm gets nod for acne treatment Winlevi - koreabiomed.com","headline":"Hyundai Pharm gets nod for acne treatment Winlevi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiS0FVX3lxTE1QTnRVVkp0eVIwS1I1NEZZV2l2MFFVbGpsY2pncFNyOHUtenlIcFNOeFRRd01kSGpQN0lKWEMtWjg1T3hvbzhxd3VJcw?oc=5","date":"2025-08-02","type":"deal","source":"매일경제","summary":"Hello, readers. Did you have a good last week.Recently, MK Pharmacy mainly dealt with summer disease.. - 매일경제","headline":"Hello, readers. Did you have a good last week.Recently, MK Pharmacy mainly dealt with summer disease.. - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9fUWRLeGNZRDRSbXpRRFRpVmVsUkpBOGZKbC1ZLVZfanBOMDlMc0ZHUGN1R3FrZUZ2ZFdkejBFY2swaHhzUnRMaHRsUHhKaTNJNDVlOF9zaV9GN0cwMlFENnpzVlYyUUhMS3YzdHVn0gFyQVVfeXFMT1c1c21CV1l3V2VCaWlQOThrc0FNZzYtWld1MG1sMFJoaktRVkJvdmItMWZxRHd1ZW41ZHlYZndxZW9lY3hFWHRQZXJneVdWRXVVX0FXNkg2bl9tNTFHZ2M5VGdCSzA5Skc0em52ZkxoV3Zn?oc=5","date":"2025-06-24","type":"patent","source":"koreabiomed.com","summary":"After 9-year wait, Boehringer’s IPF drug Ofev faces generic threat weeks into Korea launch - koreabiomed.com","headline":"After 9-year wait, Boehringer’s IPF drug Ofev faces generic threat weeks into Korea launch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE4zOElGN1RZcXFxX0lUZW1rUGp1clptYjlPb3ZyX2FnYUJrdjJGbWFtTEQ1cUMxb3FwVU1YdEFmWU5XUmFBVnZWT2VpTWVjU3NCQ2lLUDR6cE5Lc0lGZ19iZjl1NGhLdDF1TlBtZlVR0gFyQVVfeXFMTjNrekxkaVQ3UXJZWW5DZjdnWDd4b05Xa2JTbFcxZFVIVk42c1BKTjUwMkNnMFBVUjVzZnFGOWVnYWdWelJUalpnN3pDa28yUm5RdlVwUVc5U09EYmowYlg2NndiRkNsNU1pRU9xejNpN0hR?oc=5","date":"2025-01-03","type":"regulatory","source":"koreabiomed.com","summary":"Hyundai Pharm reapplies for approval of abortion pill Mifegymiso - koreabiomed.com","headline":"Hyundai Pharm reapplies for approval of abortion pill Mifegymiso","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1aQUY3aWFJLThTcGtHUnBpUWliUUlMeVdsS3dPQVo0czJLUmtMV2pRbWlxa1hfVHNXMkw2bVItN2tfQmczc2tMTE9FakttVEMwUGxZWmdWN1MyaUdvZXEyLXdpemM1Q3NWQURnQ0lR0gFyQVVfeXFMTmFlX0NlLXdocEU0Uzk3TXB6ek5kMVRiZWJBSGdITmVLOHl3dVN5RUFJT184dG1jSGZESFg5VHU2a204VmJEb2JTTE9VeVhpWmVoUTkzU2ktQmREeG1xblZIdzllM3owV3E4WUkyRENOU1h3?oc=5","date":"2024-08-20","type":"regulatory","source":"koreabiomed.com","summary":"Hyundai Pharm obtains approval for new contraceptive - koreabiomed.com","headline":"Hyundai Pharm obtains approval for new contraceptive","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBEaXlRc3dxZWo5QXl3bElMY05xazh3SW55cDl2OTlTcVNHMmlQZllzbWJ2ZW5zSUZxYUZTUl9QY2tHM2NIWEhReWl1eXo0SXJXSjRMY0Z0dU9oMmVFUWk4WDM4VWdLNjBkd3NfNTVn0gFyQVVfeXFMTWpZLTBTNjdZNmRKcjBmZkhFRm1Mc0M4Mlo5SXN6S1FUdnlyUklzRC1iZkFsMU1sZENhdlhXdU1BdHhKTU9pMUxaV1ZWcG4zckZ6RXpWSl9uVmllU2g4THI4dExXaHlhV1djbndFYW00b3JR?oc=5","date":"2023-07-03","type":"regulatory","source":"koreabiomed.com","summary":"Hyundai Pharm accidentally labels hypertension drug as dementia treatment, endangering patients - koreabiomed.com","headline":"Hyundai Pharm accidentally labels hypertension drug as dementia treatment, endangering patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1qWDU4Zm9uT0VjTXY3Sm9lclEyU21zR0d6S3NSY3d6YWVQanBVeXQ0M25NazZkOHlGX0hkcmVHdlh1TjVtX18tVFNZMmtoSHk1clFPWDBsUGZVTGpHamJfdDZ0Vy1fUHMyQ0lkeXdB0gFyQVVfeXFMT25mQVF0elZPYmI2V1p1QUxJR2k3UWRyY25YOXVjUUNteDd2T3Z0ZU9laVItWm1RcXlMSzU4NlM0eFZrM3g4OUFxUlRXaG1YUjVidk91dmJTZlNwWlVhaWFxXzdjaUM0VnNMRzk5cENqOUxB?oc=5","date":"2023-01-02","type":"pipeline","source":"koreabiomed.com","summary":"Hyundai Pharm to launch its 20 mg Alzheimer’s drug - koreabiomed.com","headline":"Hyundai Pharm to launch its 20 mg Alzheimer’s drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTFBfeXJScTRxU2Q4YlRuOW41SlhOQ2laWE80R0lPSnk1QUhCY1ZfVTNaQzBvSkFidlROdm80cnVHbHhtS0h1ZkNrWXFnTkxWb0JIdHBoZzdn?oc=5","date":"2022-12-16","type":"regulatory","source":"The Korea Herald","summary":"Hyundai Pharm withdraws application for abortion pill approval - The Korea Herald","headline":"Hyundai Pharm withdraws application for abortion pill approval","sentiment":"positive"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":3,"phase_1":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}